<DOC>
	<DOCNO>NCT03098563</DOCNO>
	<brief_summary>This research do evaluate whether combine medication FDA approve , yet approve combination treatment , effective reduce pain .</brief_summary>
	<brief_title>Maximizing Analgesia Reduce Pain Knee Osteoarthritis</brief_title>
	<detailed_description>This study evaluate whether combination pharmacotherapies effectively alleviate pain . Subjects complete two screening session complete four study session occur weekly . Participants receive double blind dos study medication morning experimental session day undergo standardized pain testing , physical functioning assessment , blood draw , rating drug effect cognitive testing .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Diagnosis knee osteoarthritis Urine sample test negative common illicit substance abuse ( e.g. , cannabis ) Medically clear take study medication Are pregnant breast feed Willing comply study protocol . Pain Knee Osteoarthritis Taking opioids pain Prescribed take gabapentinoid , TCA , venlafaxine , duloxetine , stimulant benzodiazepine Presence clinically significant medical/psychiatric illness judge investigator put subject elevate risk experience adverse event Known allergy blind study medication</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Clinical Trial</keyword>
	<keyword>Phase II</keyword>
</DOC>